3-[[3-[(1S,1aS,6aR)-1,1a,6,6a-tetrahydrocyclopropa[a]inden-1-yl]-1,2,4-oxadiazol-5-yl]methyl]-6-[(1R,1aR,6aS)-1-[5-[(5-methyl-4-oxopyrido[3,4-d]pyrimidin-3-yl)methyl]-1,2,4-oxadiazol-3-yl]-1,1a,6,6a-tetrahydrocyclopropa[a]inden-4-yl]-5-methylpyrido[3,4-d]pyrimidin-4-one

C42H32N10O4 — CID 142422329

IUPAC3-[[3-[(1S,1aS,6aR)-1,1a,6,6a-tetrahydrocyclopropa[a]inden-1-yl]-1,2,4-oxadiazol-5-yl]methyl]-6-[(1R,1aR,6aS)-1-[5-[(5-methyl-4-oxopyrido[3,4-d]pyrimidin-3-yl)methyl]-1,2,4-oxadiazol-3-yl]-1,1a,6,6a-tetrahydrocyclopropa[a]inden-4-yl]-5-methylpyrido[3,4-d]pyrimidin-4-one
SMILESCc1cncc2ncn(Cc3nc([C@@H]4[C@H]5Cc6cc(-c7ncc8ncn(Cc9nc([C@H]%10[C@@H]%11Cc%12ccccc%12[C@@H]%11%10)no9)c(=O)c8c7C)ccc6[C@H]54)no3)c(=O)c12
InChIInChI=1S/C42H32N10O4/c1-19-12-43-13-28-32(19)41(53)51(17-45-28)15-30-47-40(50-55-30)37-27-11-23-9-22(7-8-25(23)35(27)37)38-20(2)33-29(14-44-38)46-18-52(42(33)54)16-31-48-39(49-56-31)36-26-10-21-5-3-4-6-24(21)34(26)36/h3-9,12-14,17-18,26-27,34-37H,10-11,15-16H2,1-2H3/t26-,27+,34+,35-,36+,37-/m1/s1
InChIKeyYJKMPZAJBSPLRE-YZNGTIMRSA-N
MW740.78 g/mol
LogP5.15
Rot. Bonds7

About 3-[[3-[(1S,1aS,6aR)-1,1a,6,6a-tetrahydrocyclopropa[a]inden-1-yl]-1,2,4-oxadiazol-5-yl]methyl]-6-[(1R,1aR,6aS)-1-[5-[(5-methyl-4-oxopyrido[3,4-d]pyrimidin-3-yl)methyl]-1,2,4-oxadiazol-3-yl]-1,1a,6,6a-tetrahydrocyclopropa[a]inden-4-yl]-5-methylpyrido[3,4-d]pyrimidin-4-one

3-[[3-[(1S,1aS,6aR)-1,1a,6,6a-tetrahydrocyclopropa[a]inden-1-yl]-1,2,4-oxadiazol-5-yl]methyl]-6-[(1R,1aR,6aS)-1-[5-[(5-methyl-4-oxopyrido[3,4-d]pyrimidin-3-yl)methyl]-1,2,4-oxadiazol-3-yl]-1,1a,6,6a-tetrahydrocyclopropa[a]inden-4-yl]-5-methylpyrido[3,4-d]pyrimidin-4-one (PubChem CID 142422329) has the molecular formula C42H32N10O4 and a molecular weight of 740.78 g/mol. Its IUPAC name is 3-[[3-[(1S,1aS,6aR)-1,1a,6,6a-tetrahydrocyclopropa[a]inden-1-yl]-1,2,4-oxadiazol-5-yl]methyl]-6-[(1R,1aR,6aS)-1-[5-[(5-methyl-4-oxopyrido[3,4-d]pyrimidin-3-yl)methyl]-1,2,4-oxadiazol-3-yl]-1,1a,6,6a-tetrahydrocyclopropa[a]inden-4-yl]-5-methylpyrido[3,4-d]pyrimidin-4-one.

Molecular Properties

Compound Name3-[[3-[(1S,1aS,6aR)-1,1a,6,6a-tetrahydrocyclopropa[a]inden-1-yl]-1,2,4-oxadiazol-5-yl]methyl]-6-[(1R,1aR,6aS)-1-[5-[(5-methyl-4-oxopyrido[3,4-d]pyrimidin-3-yl)methyl]-1,2,4-oxadiazol-3-yl]-1,1a,6,6a-tetrahydrocyclopropa[a]inden-4-yl]-5-methylpyrido[3,4-d]pyrimidin-4-one
PubChem CID142422329
Molecular FormulaC42H32N10O4
Molecular Weight740.78 g/mol
Exact Mass740.26
IUPAC Name3-[[3-[(1S,1aS,6aR)-1,1a,6,6a-tetrahydrocyclopropa[a]inden-1-yl]-1,2,4-oxadiazol-5-yl]methyl]-6-[(1R,1aR,6aS)-1-[5-[(5-methyl-4-oxopyrido[3,4-d]pyrimidin-3-yl)methyl]-1,2,4-oxadiazol-3-yl]-1,1a,6,6a-tetrahydrocyclopropa[a]inden-4-yl]-5-methylpyrido[3,4-d]pyrimidin-4-one
SMILESCc1cncc2ncn(Cc3nc([C@@H]4[C@H]5Cc6cc(-c7ncc8ncn(Cc9nc([C@H]%10[C@@H]%11Cc%12ccccc%12[C@@H]%11%10)no9)c(=O)c8c7C)ccc6[C@H]54)no3)c(=O)c12
InChIInChI=1S/C42H32N10O4/c1-19-12-43-13-28-32(19)41(53)51(17-45-28)15-30-47-40(50-55-30)37-27-11-23-9-22(7-8-25(23)35(27)37)38-20(2)33-29(14-44-38)46-18-52(42(33)54)16-31-48-39(49-56-31)36-26-10-21-5-3-4-6-24(21)34(26)36/h3-9,12-14,17-18,26-27,34-37H,10-11,15-16H2,1-2H3/t26-,27+,34+,35-,36+,37-/m1/s1
InChIKeyYJKMPZAJBSPLRE-YZNGTIMRSA-N
XLogP5.15
TPSA173.40 Ų
H-Bond Donors
H-Bond Acceptors14
Rotatable Bonds7
Heavy Atoms56
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500740.78
LogP ≤ 55.15
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1014

Analyze 3-[[3-[(1S,1aS,6aR)-1,1a,6,6a-tetrahydrocyclopropa[a]inden-1-yl]-1,2,4-oxadiazol-5-yl]methyl]-6-[(1R,1aR,6aS)-1-[5-[(5-methyl-4-oxopyrido[3,4-d]pyrimidin-3-yl)methyl]-1,2,4-oxadiazol-3-yl]-1,1a,6,6a-tetrahydrocyclopropa[a]inden-4-yl]-5-methylpyrido[3,4-d]pyrimidin-4-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[[3-[(1S,1aS,6aR)-1,1a,6,6a-tetrahydrocyclopropa[a]inden-1-yl]-1,2,4-oxadiazol-5-yl]methyl]-6-[(1R,1aR,6aS)-1-[5-[(5-methyl-4-oxopyrido[3,4-d]pyrimidin-3-yl)methyl]-1,2,4-oxadiazol-3-yl]-1,1a,6,6a-tetrahydrocyclopropa[a]inden-4-yl]-5-methylpyrido[3,4-d]pyrimidin-4-one?
The IUPAC name of 3-[[3-[(1S,1aS,6aR)-1,1a,6,6a-tetrahydrocyclopropa[a]inden-1-yl]-1,2,4-oxadiazol-5-yl]methyl]-6-[(1R,1aR,6aS)-1-[5-[(5-methyl-4-oxopyrido[3,4-d]pyrimidin-3-yl)methyl]-1,2,4-oxadiazol-3-yl]-1,1a,6,6a-tetrahydrocyclopropa[a]inden-4-yl]-5-methylpyrido[3,4-d]pyrimidin-4-one (CID 142422329) is 3-[[3-[(1S,1aS,6aR)-1,1a,6,6a-tetrahydrocyclopropa[a]inden-1-yl]-1,2,4-oxadiazol-5-yl]methyl]-6-[(1R,1aR,6aS)-1-[5-[(5-methyl-4-oxopyrido[3,4-d]pyrimidin-3-yl)methyl]-1,2,4-oxadiazol-3-yl]-1,1a,6,6a-tetrahydrocyclopropa[a]inden-4-yl]-5-methylpyrido[3,4-d]pyrimidin-4-one.
What is the SMILES notation for 3-[[3-[(1S,1aS,6aR)-1,1a,6,6a-tetrahydrocyclopropa[a]inden-1-yl]-1,2,4-oxadiazol-5-yl]methyl]-6-[(1R,1aR,6aS)-1-[5-[(5-methyl-4-oxopyrido[3,4-d]pyrimidin-3-yl)methyl]-1,2,4-oxadiazol-3-yl]-1,1a,6,6a-tetrahydrocyclopropa[a]inden-4-yl]-5-methylpyrido[3,4-d]pyrimidin-4-one?
The canonical SMILES for 3-[[3-[(1S,1aS,6aR)-1,1a,6,6a-tetrahydrocyclopropa[a]inden-1-yl]-1,2,4-oxadiazol-5-yl]methyl]-6-[(1R,1aR,6aS)-1-[5-[(5-methyl-4-oxopyrido[3,4-d]pyrimidin-3-yl)methyl]-1,2,4-oxadiazol-3-yl]-1,1a,6,6a-tetrahydrocyclopropa[a]inden-4-yl]-5-methylpyrido[3,4-d]pyrimidin-4-one is Cc1cncc2ncn(Cc3nc([C@@H]4[C@H]5Cc6cc(-c7ncc8ncn(Cc9nc([C@H]%10[C@@H]%11Cc%12ccccc%12[C@@H]%11%10)no9)c(=O)c8c7C)ccc6[C@H]54)no3)c(=O)c12.
What is the InChIKey of 3-[[3-[(1S,1aS,6aR)-1,1a,6,6a-tetrahydrocyclopropa[a]inden-1-yl]-1,2,4-oxadiazol-5-yl]methyl]-6-[(1R,1aR,6aS)-1-[5-[(5-methyl-4-oxopyrido[3,4-d]pyrimidin-3-yl)methyl]-1,2,4-oxadiazol-3-yl]-1,1a,6,6a-tetrahydrocyclopropa[a]inden-4-yl]-5-methylpyrido[3,4-d]pyrimidin-4-one?
The InChIKey is YJKMPZAJBSPLRE-YZNGTIMRSA-N. The full InChI is InChI=1S/C42H32N10O4/c1-19-12-43-13-28-32(19)41(53)51(17-45-28)15-30-47-40(50-55-30)37-27-11-23-9-22(7-8-25(23)35(27)37)38-20(2)33-29(14-44-38)46-18-52(42(33)54)16-31-48-39(49-56-31)36-26-10-21-5-3-4-6-24(21)34(26)36/h3-9,12-14,17-18,26-27,34-37H,10-11,15-16H2,1-2H3/t26-,27+,34+,35-,36+,37-/m1/s1.
What are the key properties of 3-[[3-[(1S,1aS,6aR)-1,1a,6,6a-tetrahydrocyclopropa[a]inden-1-yl]-1,2,4-oxadiazol-5-yl]methyl]-6-[(1R,1aR,6aS)-1-[5-[(5-methyl-4-oxopyrido[3,4-d]pyrimidin-3-yl)methyl]-1,2,4-oxadiazol-3-yl]-1,1a,6,6a-tetrahydrocyclopropa[a]inden-4-yl]-5-methylpyrido[3,4-d]pyrimidin-4-one?
3-[[3-[(1S,1aS,6aR)-1,1a,6,6a-tetrahydrocyclopropa[a]inden-1-yl]-1,2,4-oxadiazol-5-yl]methyl]-6-[(1R,1aR,6aS)-1-[5-[(5-methyl-4-oxopyrido[3,4-d]pyrimidin-3-yl)methyl]-1,2,4-oxadiazol-3-yl]-1,1a,6,6a-tetrahydrocyclopropa[a]inden-4-yl]-5-methylpyrido[3,4-d]pyrimidin-4-one has a molecular weight of 740.78 g/mol, XLogP of 5.15, 7 rotatable bonds, 0 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[[3-[(1S,1aS,6aR)-1,1a,6,6a-tetrahydrocyclopropa[a]inden-1-yl]-1,2,4-oxadiazol-5-yl]methyl]-6-[(1R,1aR,6aS)-1-[5-[(5-methyl-4-oxopyrido[3,4-d]pyrimidin-3-yl)methyl]-1,2,4-oxadiazol-3-yl]-1,1a,6,6a-tetrahydrocyclopropa[a]inden-4-yl]-5-methylpyrido[3,4-d]pyrimidin-4-one is sourced from PubChem (CID 142422329), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).